Wanessa Christina Souza-Neiras, Gustavo Capatti Cassiano, Luciane Moreno Storti-Melo, Luzia H. Carvalho, Sócrates Herrera, Myrian Arevalo-Herrera, Ricardo Luiz Dantas Machado, Andréa Regina Baptista Rossit, Irene S. Soares, Vanja Suely Calvosa D’Almeida Couto, José Antônio Cordeiro, Luiz Carlos de Mattos, Daniela Reis da Costa, Marinete Marins Póvoa, Universidade Federal de Sergipe (UFS), Faculdade de Medicina de São José do Rio Preto (FAMERP), Universidade Federal do Triângulo Mineiro (UFTM), Universidade Estadual Paulista (Unesp), Nucleo Estadual Amapa CRDT, Secretaria Vigilancia Saude, Universidade de São Paulo (USP), Fundação Oswaldo Cruz, Univ Valle, and Universidade Federal Fluminense (UFF)
Made available in DSpace on 2013-09-27T14:52:56Z (GMT). No. of bitstreams: 1 WOS000300132800014.pdf: 212581 bytes, checksum: 6535572dbec9f900d22c06ab647009a4 (MD5) Previous issue date: 2012-02-01 Made available in DSpace on 2013-09-30T19:24:38Z (GMT). No. of bitstreams: 1 WOS000300132800014.pdf: 212581 bytes, checksum: 6535572dbec9f900d22c06ab647009a4 (MD5) Previous issue date: 2012-02-01 Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-20T15:34:42Z No. of bitstreams: 1 WOS000300132800014.pdf: 212581 bytes, checksum: 6535572dbec9f900d22c06ab647009a4 (MD5) Made available in DSpace on 2014-05-20T15:34:42Z (GMT). No. of bitstreams: 1 WOS000300132800014.pdf: 212581 bytes, checksum: 6535572dbec9f900d22c06ab647009a4 (MD5) Previous issue date: 2012-02-01 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) COLCIENCIAS Ministry of Social Protection National Institute of Allergy and Infectious Diseases (NIAID) We evaluated the influence of allelic frequency of the human leukocyte antigen (HLA) -DRB1 on the acquisition of antibody response against malaria sporozoite and merozoite peptides in patients with Plasmodium vivax malaria acquired in endemic areas of Brazil. IgG antibodies were detected by enzyme-linked immunosorbent assay against four peptides of circumsporozoite protein (CSP) (amino, carboxyl, and VK210 and VK247 repeats) and peptides of merozoite surface protein 1 (MSP-1), apical membrane antigen 1 (AMA-1), and Duffy-binding protein (DBP). We found an association between HLA-DR3 and HLA-DR5 alleles and lack of antibody response to CSP amino terminal, as well as an association between HILA-DR3 and the highest antibody response to MSP1 (Pv200L). In conclusion, we suggest a potential regulatory role of the H1A-DRB1 alleles in the production of antibodies to a conserved region of P. vivax CSP and MSP1 in Brazilian population exposed to malaria. (C) 2011 Elsevier B.V. All rights reserved. Univ Fed Sergipe, Dept Biociencias, BR-49500000 Itabaiana, SE, Brazil Faculdade de Medicina de São José do Rio Preto (FAMERP), Dept Doencas Dermatol Infecciosas & Parasitarias, Ctr Invest Microrganismos, BR-15090000 São Paulo, Brazil Univ Fed Triangulo Mineiro, Inst Ciencias Exatas Nat & Educ, BR-38025180 Uberaba, MC, Brazil Univ Estadual Paulista, BR-15054000 São Paulo, Brazil Nucleo Estadual Amapa CRDT, Minist Saude, BR-68900430 Macapa, Amapa, Brazil Secretaria Vigilancia Saude, Inst Evandro Chagas, Lab Pesquisas Basicas Malaria, BR-6703000 Ananindeua, Para, Brazil Univ São Paulo, Fac Ciencias Farmaceut, BR-05508900 São Paulo, Brazil Fundação Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Malaria, BR-30190002 Belo Horizonte, MG, Brazil Univ Valle, Fac Salud, Inst Inmunol, Cali, Colombia Univ Fed Fluminense, Inst Biomed, Dept Microbiol & Parasitol, BR-24210130 Rio de Janeiro, Brazil Faculdade de Medicina de São José do Rio Preto (FAMERP), Dept Epidemiol, BR-15090000 São Paulo, Brazil Faculdade de Medicina de São José do Rio Preto (FAMERP), Dept Biol Mol, Lab Imunohematol, BR-15090000 São Paulo, Brazil Univ Estadual Paulista, BR-15054000 São Paulo, Brazil FAPESP: 02/09546-1 FAPESP: 06/09546-1 CNPq: 302353/03-8 CNPq: 410405/2006-0 COLCIENCIAS: 1106-04-16489) Ministry of Social Protection: 2304-04-19524 Ministry of Social Protection: 253-2005 National Institute of Allergy and Infectious Diseases (NIAID): 49486/TMRC